|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 215/42 | (2006.01) |
| A61K 31/4709 | (2013.01) | ||
| A61K 31/4706 | (2006.01) | ||
| A61K 31/4985 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07D 215/42 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Patento numeris | 3521283 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19157824.4 |
| Europos patento paraiškos padavimo data | 2010-06-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-08-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-02-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 18655209 P | 2009-06-12 | US | |
| 18654409 P | 2009-06-12 | US | |
| 09162630 | 2009-06-12 | EP | |
| 09305540 | 2009-06-12 | EP |
| (72) |
ROUX, Pierre , FR
MAHUTEAU, Florence , FR
NAJMAN, Romain , FR
TAZI, Jamal , FR
GADEA, Gilles , FR
|
| (73) |
ABIVAX ,
7-11 Boulevard Haussmann, 75009 Paris,
FR
Centre National de la Recherche Scientifique , 3 Rue Michel Ange, 75794 Paris Cedex 16, FR Institut Curie , 26, rue d'Ulm, 75248 Paris Cedex 05, FR UNIVERSITE DE MONTPELLIER , 163, rue Auguste Broussonnet, 34090 Montpellier, FR |
| (54) | COMPOUNDS USEFUL FOR TREATING CANCER |
| COMPOUNDS USEFUL FOR TREATING CANCER |